DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a second-quarter loss of $14.1 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Dublin-based company said it had a loss of 3 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 66 cents per share.
The biopharmaceutical company posted revenue of $72.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $45.5 million.
Amarin shares have climbed 51% since the beginning of the year. The stock has decreased 6% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
